{"id":"h077-sustained-release-tablet","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Dizziness"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This action results in increased levels of the neurotransmitter in the synaptic cleft, leading to enhanced neurotransmission. The sustained-release formulation allows for a prolonged duration of action, providing consistent therapeutic effects over an extended period.","oneSentence":"H077 sustained-release tablet is a medication that works by inhibiting the reuptake of a specific neurotransmitter.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:14:49.153Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Major depressive disorder"}]},"trialDetails":[{"nctId":"NCT07146386","phase":"PHASE3","title":"A Phase III Clinical Study of H077 Sustained-Release Tablets Compared With Silodosin Capsules in the Treatment of Benign Prostatic Hyperplasia","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Huilun Pharmaceutical Co., Ltd.","startDate":"2025-08","conditions":"Benign Prostatic Hyperplasia, Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms","enrollment":728}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"H077 sustained-release tablet","genericName":"H077 sustained-release tablet","companyName":"Shanghai Huilun Pharmaceutical Co., Ltd.","companyId":"shanghai-huilun-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"H077 sustained-release tablet is a medication that works by inhibiting the reuptake of a specific neurotransmitter. Used for Major depressive disorder.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}